AquaBounty Technologies, Inc. (AQB) came out with a quarterly loss of $0.88 per share versus the Zacks Consensus Estimate of a loss of $0.89. This compares to loss of $1.60 per share a year ago.
AquaBounty Technologies, Inc. (AQB) came out with a quarterly loss of $1.56 per share versus the Zacks Consensus Estimate of a loss of $0.93. This compares to loss of $1.80 per share a year ago.
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
| RS Richard Slavik Newbridge Financial Services Group Inc. | 250 | $712.5 | $250 | -$462.5 | -64.91% |
Christopher C. Powers Farther Finance Advisors, LLC | 167 | $374 | $167 | -$207 | -55.35% |
Kevin Bresler TD Waterhouse Canada Inc. | 10 | $9 | $10 | $1 | 11.11% |
Matthew Cochran Atlantic Edge Private Wealth Management, LLC | 14 | $40 | $14 | -$26 | -65% |
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
| KD Kevin Dede HC Wainwright & Co. | -12,742.98 | $33,982.03 | $12,742.98 | $21,239.05 | 62.5% |
| CR Colin Rusch Oppenheimer | -80,851.06 | $228,590.68 | $80,851.06 | $147,739.62 | 64.63% |
| Food Products Industry | Consumer Staples Sector | David A. Frank CEO | NASDAQ (CM) Exchange | 03842K200 CUSIP |
| US Country | 4 Employees | - Last Dividend | 16 Oct 2023 Last Split | 11 Jan 2017 IPO Date |
AquaBounty Technologies, Inc. is a pioneering biotechnology company that is committed to transforming the aquaculture industry through scientific innovation. With its roots in the United States and Canada, AquaBounty focuses on leveraging genetic, genomic, and advanced nutritional research to significantly enhance productivity in commercial aquaculture. The company has successfully developed proprietary technology for salmon farming, which it uses in its operations. Initially established as Aqua Bounty Farms, Inc., the organization underwent a name change to AquaBounty Technologies, Inc. in June 2004, marking a new era of growth and innovation. Since its inception in 1991, AquaBounty has been headquartered in Maynard, Massachusetts, positioning itself as a leader in sustainable aquaculture practices and technology.
This groundbreaking product is at the heart of AquaBounty's offerings. AquAdvantage Salmon is a genetically engineered Atlantic salmon designed to grow faster than its non-genetically modified counterpart. This bioengineered salmon is intended for human consumption, catering to the growing demand for sustainable and efficiently produced seafood. Through its innovative genetic modifications, AquAdvantage Salmon addresses key challenges in aquaculture, such as resource efficiency and environmental sustainability.
In addition to its bioengineered salmon, AquaBounty also provides consumers and businesses with conventional Atlantic salmon. This offering ensures that the company can cater to a broad market segment, including those who prefer traditional aquaculture products. AquaBounty's conventional salmon is farmed with the same commitment to quality and sustainability that characterizes all its products.
AquaBounty extends its aquaculture expertise beyond fully grown salmon to include salmon eggs and fry, which are essential components of the aquaculture lifecycle. These products are available for other aquaculture operations, promoting sustainable farming practices across the industry. Moreover, the company capitalizes on the efficient use of resources by offering byproducts, which contribute to a holistic and sustainable aquaculture ecosystem. This not only underscores AquaBounty's innovative approach to aquaculture but also their dedication to environmental stewardship and the circular economy.